In the latest trading session, Medtronic (MDT) closed at $88.58, marking a +1.04% move from the previous day. This change outpaced the S&P 500's 0.07% loss on the day. Elsewhere, the Dow saw a ...

Medtronic, which employs about 10,000 people in Minnesota, reported an adjusted net profit of $1.62 billion on $8.4 billion in sales for its second quarter, which ended Oct. 25.

Medtronic, a global healthcare technology company, announced that MiniMed is the name for the planned new diabetes company following the intended separation. The name honors the company's roots ...

Medtronic stock (NYSE: MDT) is down 9% in a week, underperforming the broader markets, with the S&P500 up 0.4%. Although the company posted upbeat Q1 results last week, the stock has declined due ...

The separation is expected to be completed in 18 months. Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company.

Medtronic in 2015 acquired the brand’s parent, Covidien, for $49.9 billion. Du, the former Medtronic ventilation executive, is now the CEO of ventilator maker Nihon Kohden OrangeMed.

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision.

STAT spoke to Medtronic CEO Geoff Martha about the company’s challenges in the diabetes and renal denervation markets, as well as his broader vision for teasing out innovative products.